Acquired immunodeficiency syndrome and the blood-brain barrier
about
The Importance of Thrombin in Cerebral Injury and DiseaseImpact of cocaine abuse on HIV pathogenesisHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsPenetrating the Blood-Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles.Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activityPlatelets Contribute to BBB Disruption Induced by HIV and Alcohol.Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsHIV-1 neuroimmunity in the era of antiretroviral therapy.HIVBrainSeqDB: a database of annotated HIV envelope sequences from brain and other anatomical sites.Pathogen-inspired drug delivery to the central nervous system.Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier.Dysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz.Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus.Viral disruption of the blood-brain barrier.Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrierHIV and co-infections.Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood-Brain BarrierNipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy.Tight junctions in the testis: new perspectives.Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.The blood-brain barrier: an engineering perspective.Harnessing nanomedicine for therapeutic intervention in glioblastoma.Normonatremic osmotic demyelination in the setting of acquired immune deficiency syndrome and malnutrition: case report and literature review.HIV-1 impairs human retinal pigment epithelial barrier function: possible association with the pathogenesis of HIV-associated retinopathy.Gliovascular and cytokine interactions modulate brain endothelial barrier in vitro.Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis.Formation of fibroblastic reticular network in the brain after infection with neurovirulent murine coronavirus.Mouse Adenovirus Type 1 Early Region 1A Effects on the Blood-Brain Barrier.Prevalence and predictors of blood-brain barrier damage in the HAART era.HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration.HIV as a Cause of Immune Activation and Immunosenescence.Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART.Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood-brain barrier into brain.
P2860
Q26772131-EE697D73-B0D1-497C-8A23-13E56E3A5819Q26779435-69C043C5-45E6-4C09-BCC5-2B168690105EQ28392199-637E15AB-4D30-48BC-8028-5139076AC82AQ30365829-99BB1FFB-7D95-4B8A-9834-599A9BB8A91AQ30532529-F1F5F488-E3E6-43BE-BC31-13BBD8E7993AQ33427030-C78028C5-5F4B-47BC-B90D-1D527057B11AQ33587139-326358A6-AE68-46FE-92FA-461D1861EC03Q33614467-F429B351-258F-4B77-88D0-A33FABD894C4Q33733529-FBEB16D3-7616-4D0D-BBAD-221B5C0C3210Q34477933-3943A41B-FF71-4F10-AD98-813269D38F5BQ34929922-72F2B322-2303-483D-B2BE-59C4EED03857Q35114694-D1D9E0C9-B841-48E6-8232-BE8E28EA86C1Q35897840-CA4C5CEE-6303-47F2-BCA1-C320B0324B17Q35931809-BE77978C-6258-4F91-8C99-F31F865A5739Q36007851-CCC2E247-D101-421F-8711-A1F4093868EAQ36298503-B68D855A-6310-466D-8A41-18D7D56D18A1Q36522639-F5F13FDD-9938-4FC8-8452-D488E8A03C0CQ36970184-6C46F1F9-837D-4797-BC39-05E17964D936Q37050722-65E19C93-3A9A-424E-8EB9-0643502203FFQ37073344-3E0E6B2A-0ABA-41C7-8B2C-47F987F0AFBDQ37312724-F744F3C0-95AC-4D73-BA25-9DBAD924497BQ37733955-931A4D50-B00C-49BE-91F3-F680D643BD91Q37974980-12641FEF-B6D7-4BBD-AD9B-90D0A323825AQ38134725-7C51769B-DB26-4821-A5F9-A3801F80D2F5Q38862946-69580599-E5ED-40C9-BB2C-84764B23E3FAQ38894270-F056F55D-B83A-45C3-A73C-7AC86A92831CQ38993792-08814103-4098-4C22-9058-9719CB6EBFA9Q40064513-7F812908-E986-43F3-AB21-6EC4CD21953DQ40262441-F2639D1F-880D-4F47-AEE3-FD81907D099BQ40322637-4DBA4E1F-A540-420D-B186-CE1002934057Q40458885-1F1D3FF7-C52B-480A-855C-9B9EA0A224D0Q40696395-F5C8AD8B-E1F2-4419-9F03-F878C8D827DCQ40700466-7DEFF700-4BD9-4335-A4CF-3D57E6ECAEA5Q42208551-9189108E-17C8-442C-B9BC-FCBFDD7B3DFCQ46617628-A835BEF0-D626-4E91-8549-437A4D224046Q47151081-9E95FCDA-021F-4DAE-9B35-5BFDD2448708Q47201399-DB249685-0394-4305-B3C5-AAF803B33000Q48503723-0E2679A6-7C26-4B6A-ADF7-B73FBAD8DA09
P2860
Acquired immunodeficiency syndrome and the blood-brain barrier
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Acquired immunodeficiency syndrome and the blood-brain barrier
@ast
Acquired immunodeficiency syndrome and the blood-brain barrier
@en
Acquired immunodeficiency syndrome and the blood-brain barrier
@nl
type
label
Acquired immunodeficiency syndrome and the blood-brain barrier
@ast
Acquired immunodeficiency syndrome and the blood-brain barrier
@en
Acquired immunodeficiency syndrome and the blood-brain barrier
@nl
prefLabel
Acquired immunodeficiency syndrome and the blood-brain barrier
@ast
Acquired immunodeficiency syndrome and the blood-brain barrier
@en
Acquired immunodeficiency syndrome and the blood-brain barrier
@nl
P2860
P3181
P1476
Acquired immunodeficiency syndrome and the blood-brain barrier
@en
P2093
Andrew A Lackner
Nathan S Ivey
P2860
P2888
P304
P3181
P356
10.1080/13550280902769764
P407
P577
2009-04-01T00:00:00Z
P5875
P6179
1032419074